Luther King Capital Management (LKCM)’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.5M | Buy |
3,541,170
+420,000
| +13% | +$1.6M | 0.06% | 151 |
|
|
2025
Q1 | $8.21M | Buy |
3,121,170
+263,260
| +9% | +$692K | 0.04% | 174 |
|
|
2024
Q4 | $10.1M | Buy |
2,857,910
+632,120
| +28% | +$2.24M | 0.04% | 161 |
|
|
2024
Q3 | $10.1M | Buy |
2,225,790
+20,650
| +0.9% | +$94.2K | 0.04% | 158 |
|
|
2024
Q2 | $9.59M | Buy |
2,205,140
+752,005
| +52% | +$3.27M | 0.04% | 158 |
|
|
2024
Q1 | $7.29M | Buy |
1,453,135
+59,610
| +4% | +$299K | 0.03% | 178 |
|
|
2023
Q4 | $8.74M | Buy |
1,393,525
+457,150
| +49% | +$2.87M | 0.04% | 161 |
|
|
2023
Q3 | $6.67M | Buy |
936,375
+377,450
| +68% | +$2.69M | 0.03% | 173 |
|
|
2023
Q2 | $5.7M | Buy |
558,925
+144,425
| +35% | +$1.47M | 0.03% | 192 |
|
|
2023
Q1 | $3.76M | Buy |
+414,500
| New | +$3.76M | 0.02% | 232 |
|